Identification of a novel MYC target gene set signature for predicting the prognosis of osteosarcoma patients

被引:0
|
作者
Gong, Deliang [1 ,2 ]
Zhao, Qingzhong [1 ,2 ]
Liu, Jun [1 ,2 ]
Zhao, Shibing [1 ,2 ]
Yi, Chengfeng [1 ,2 ]
Lv, Jianwei [1 ,2 ]
Yu, Hang [1 ,2 ]
Bian, Erbao [1 ,2 ]
Tian, Dasheng [1 ,2 ]
机构
[1] Anhui Med Univ, Affiliated Hosp 2, Dept Orthopaed, Hefei, Peoples R China
[2] Anhui Med Univ, Affiliated Hosp 2, Inst Orthopaed, Res Ctr Translat Med, Hefei, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词
MYC target gene set; osteosarcoma (OS); risk signature; prognosis; STX10; NF-KAPPA-B; YOUNG-ADULTS; C-MYC; CELL; POLARIZATION; INHIBITION; ACTIVATION; RESISTANCE; CHILDREN; SURVIVAL;
D O I
10.3389/fonc.2023.1169430
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Osteosarcoma is a primary malignant tumor found mainly in teenagers and young adults. Patients have very little long-term survival. MYC controls tumor initiation and progression by regulating the expression of its target genes; thus, constructing a risk signature of osteosarcoma MYC target gene set will benefit the evaluation of both treatment and prognosis. In this paper, we used GEO data to download the ChIP-seq data of MYC to obtain the MYC target gene. Then, a risk signature consisting of 10 MYC target genes was developed using Cox regression analysis. The signature indicates that patients in the high-risk group performed poorly. After that, we verified it in the GSE21257 dataset. In addition, the difference in tumor immune function among the low- and high-risk populations was compared by single sample gene enrichment analysis. Immunotherapy and prediction of response to the anticancer drug have shown that the risk signature of the MYC target gene set was positively correlated with immune checkpoint response and drug sensitivity. Functional analysis has demonstrated that these genes are enriched in malignant tumors. Finally, STX10 was selected for functional experimentation. STX10 silence has limited osteosarcoma cell migration, invasion, and proliferation. Therefore, these findings indicated that the MYC target gene set risk signature could be used as a potential therapeutic target and prognostic indicator in patients with osteosarcoma.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Identification of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and Responsiveness to Immunotherapy in Hepatocellular Carcinoma
    Wang, Qingbin
    Wang, Bingkun
    Ma, Xiaowu
    Zhuang, Hongkai
    Xie, Zhiqin
    Tang, Chenwei
    Tan, Wenliang
    Yang, Lei
    Shang, Changzhen
    Chen, Yajin
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 1 - 16
  • [42] Identification of a novel ADCC-related gene signature for predicting the prognosis and therapy response in lung adenocarcinoma
    Liangyu Zhang
    Xun Zhang
    Maohao Guan
    Jianshen Zeng
    Fengqiang Yu
    Fancai Lai
    Inflammation Research, 2024, 73 : 841 - 866
  • [43] Identification of a novel gene pairs signature in the prognosis of gastric cancer
    Peng, Pai-Lan
    Zhou, Xiang-Yu
    Yi, Guo-Dong
    Chen, Peng-Fei
    Wang, Fan
    Dong, Wei-Guo
    CANCER MEDICINE, 2018, 7 (02): : 344 - 350
  • [44] Development and Validation of a Novel Four Gene-Pairs Signature for Predicting Prognosis in DLBCL Patients
    Tanabe, Atsushi
    Ndzinu, Jerry
    Sahara, Hiroeki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (23)
  • [45] A Novel Gene Signature Associated With "E2F Target" Pathway for Predicting the Prognosis of Prostate Cancer
    Xia, Haoran
    Wang, Miaomiao
    Su, Xiaonan
    Lv, Zhengtong
    Yan, Qiuxia
    Guo, Xiaoxiao
    Liu, Ming
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [46] A Novel Ten-Gene Signature Predicting Prognosis in Hepatocellular Carcinoma
    Zhou, Taicheng
    Cai, Zhihua
    Ma, Ning
    Xie, Wenzhuan
    Gao, Chan
    Huang, Mengli
    Bai, Yuezong
    Ni, Yangpeng
    Tang, Yunqiang
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [47] A novel NET-related gene signature for predicting DLBCL prognosis
    Shi, Huizhong
    Pan, Yiming
    Xiang, Guifen
    Wang, Mingwei
    Huang, Yusong
    He, Liu
    Wang, Jue
    Fang, Qian
    Li, Ling
    Liu, Zhong
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [48] A novel four-gene signature for predicting the prognosis of hepatocellular carcinoma
    Sun, Ying
    Chen, Zhi-Yong
    Gan, Xia
    Dai, Hua
    Cai, Dan
    Liu, Rong-Hua
    Zhou, Jian-Ming
    Zhang, Hong-Li
    Li, Zi-Hua
    Luo, Qing-Qing
    Jiang, Song
    Wang, Ting
    Zhang, Kun-He
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2022, 57 (10) : 1227 - 1237
  • [49] A novel NET-related gene signature for predicting DLBCL prognosis
    Huizhong Shi
    Yiming Pan
    Guifen Xiang
    Mingwei Wang
    Yusong Huang
    Liu He
    Jue Wang
    Qian Fang
    Ling Li
    Zhong Liu
    Journal of Translational Medicine, 21
  • [50] Four metastasis associated gene signatures for predicting the prognosis of osteosarcoma patients
    Yu, Z. X.
    Zhao, Z.
    Dong, C.
    Xu, K.
    Zhang, H.
    Niu, S.
    Long, H.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2021, 35 (05): : 1505 - 1520